Commure vs Trase
Two RCM Automation Platforms vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Commure | Trase | |
|---|---|---|
| Pricing model | Enterprise contract (custom) · Custom deals across a broad product suite | Enterprise contract (custom) · No upfront fee, billed on efficiency gains |
| Speed to go live | Deep EHR and RCM integration for full suite | Prebuilt agent library deploys in weeks |
| Automation model | Software platform · Ambient AI plus RCM automation suite | Autonomous agents · Governed agent OS for regulated work |
| Built for | Mid-size groups, Enterprise systems | Enterprise systems |
| Security posture | SOC 2 Type II, HIPAA | SOC 2 Type I, HIPAA |
| Company maturity | 9 yrs (est. 2017) | Not disclosed |
| Financial backing | $1B+ · Late-stage private, $7B valuation (2026) | $117.5M ($10.5M pre-seed plus $107M seed) · Seed |
| Named customers | 4 named | 2 named |
| Published results | No public numbers | Specific numbers public |
| Documented integrations | 4 listed | None documented |
| Third-party validation | None found | None found |
Bottom line
- Pick Commure if you're an enterprise health system that wants ambient documentation and revenue cycle automation consolidated under one vendor.
- Pick Trase if you are an academic or large health system that wants governed AI agents across back-office workflows and prefers paying from measured efficiency gains.
Commure
AI platform for clinical documentation and revenue cycle work
- Founded
- 2017
- HQ
- San Francisco, CA
- Stage
- Late-stage private, $7B valuation (2026)
- Raised
- $1B+
What it does
- Ambient AI clinical documentation (scribing)
- Revenue cycle automation across front, middle, and back office
- Practice management and billing for medical groups
- Clinician workflow tools (PatientKeeper lineage)
- Staff duress and safety badges (Strongline)
- Patient engagement and care management (Memora)
Where it's strong
- Deep General Catalyst backing and health system relationships give it staying power and large reference customers like HCA.
- Breadth is unusual: one contract can cover ambient documentation, RCM automation, and practice management.
- Claims deployment across 130+ health systems and 3,000+ sites, so it has real enterprise scale.
What buyers should weigh
- The platform is an assembly of acquired products (Athelas, PatientKeeper, Augmedix, Memora), so integration depth varies by module.
- Fast growth by M&A means product roadmaps and account teams can shift; ask which products are strategic.
- Its marquee metrics (85%+ touchless RCM work) are vendor-reported and worth validating in a pilot.
Named customers
HCA Healthcare · Tenet Healthcare · Jefferson Health · Providence
Integrations
Trase
Governed AI agents for healthcare back-office work
- Founded
- n/a
- HQ
- McLean, VA
- Stage
- Seed
- Raised
- $117.5M ($10.5M pre-seed plus $107M seed)
What it does
- AI agents for inbound fax triage and routing
- Patient access workflow automation
- Revenue cycle task automation
- HIPAA and SOC 2 compliant agent platform
- Governance and oversight controls for agent actions
Where it's strong
- Live health system deployment at Duke, where fax triage ran 7.1 times faster than manual processing and saved about 1,395 staff hours a month.
- The $107M seed led by ARCH Venture Partners gives it unusual capital depth for a company at this stage.
- Pricing tied to measured efficiency gains lowers the risk of paying for software that does not perform.
What buyers should weigh
- The company only came out of stealth in November 2025, so the reference base beyond Duke Health is thin.
- The platform spans healthcare, defense, and other regulated industries, so healthcare-specific product depth may lag single-focus rivals.
- Published results center on fax triage; patient access and RCM claims have less public evidence.
Named customers
Duke Health · U.S. Navy
Compare against the rest of RCM Automation Platforms
Deciding between these two?
First Pass tracks RCM Automation Platforms every week: funding, launches, and what changed since this page was written.